Massachusetts Institute of Technology cell biologist Chris Kaiser, who was to tapped to take over the leadership of the National Institute of General Medical Sciences, withdrew from the job in late April.
Kaiser cited personal reasons for the decision, which was reported by Lawrence Tabak, the principal deputy director at the National Institutes of Health, in a memo to acting NIGMS director Judith Greenberg. Greenberg had taken over after the departure of Jeremy Berg, who is the incoming president of the American Society for Biochemistry and Molecular Biology and associate senior vice chancellor at the University of Pittsburgh.
NIGMS has a $2 billion basic research budget that supports more than 4,500 grants. In its portfolio are many programs aimed at increasing the diversity of the biomedical and behavioral research workforce.